Product Information
METRONIDAZOLE TOPICAL 0.75% GL is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1793 per GM under NDC 51672411606. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 18, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672411606
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA077819FDA Approved
7/18/2006
TE Code
AB
On Market Since
7/18/2006
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE TOPICAL 0.75% GL has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 93.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1793 per GM |
|---|---|
| All-time high | $2.7335 (Feb 12, 2014) |
| All-time low | $0.1793 (Sep 23, 2026) |
| 52-week high | $0.4059 |
| 52-week low | $0.1793 |
| Median price | $0.9385 |
| Average price | $1.1452 |
| Largest weekly change | +29.4% (Oct 23, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metronidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE TOPICAL 0.75% GL?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE TOPICAL 0.75% GL, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1793 per GM (NDC 51672411606), effective Sep 30, 2026.
How has the price of METRONIDAZOLE TOPICAL 0.75% GL changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE TOPICAL 0.75% GL has declined 93.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE TOPICAL 0.75% GL?
Since Nov 28, 2013, the NADAC for METRONIDAZOLE TOPICAL 0.75% GL has ranged from a low of $0.1793 (Sep 23, 2026) to a high of $2.7335 (Feb 12, 2014), with a median of $0.9385 per GM.
Are there cheaper alternatives to METRONIDAZOLE TOPICAL 0.75% GL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE VAGINAL 0.75% GL, is $0.1406 per GM — about 22% below METRONIDAZOLE TOPICAL 0.75% GL.
Who manufactures METRONIDAZOLE TOPICAL 0.75% GL?
METRONIDAZOLE TOPICAL 0.75% GL (NDC 51672411606) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.